sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Cysteine

Medicine · Vitamin C

Cysteine

Cysteine hydrochloride injection, USP is indicated for use as an additive to amino acids solutions to meet nutritional requirements of neonates (preterm and term infants less than one month of age) requiring total parenteral nutrition.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
Cysteine hydrochloride injection, USP is indicated for use as an additive to amino acids solutions to meet nutritional requirements of neonates (preterm and term infants less than one month of age) requiring total parenteral nutrition.
Do not take if
  • Patients with known hypersensitivity to one or more amino acids.
  • Patients with inborn errors of amino acid metabolism due to risk of severe metabolic or neurologic complications.
  • Patients with pulmonary edema or acidosis due to low cardiac output.

Side effects, and when to stop

The following serious adverse reactions are discussed in greater detail in other sections of the prescribing information:

  • Pulmonary embolism due to pulmonary vascular precipitates
  • Vein damage and thrombosis
  • Increased BUN
  • Acid-base imbalance
  • Hepatobiliary disorders
  • Aluminum toxicity

Adverse reactions with the use of cysteine hydrochloride injection were identified in clinical studies or postmarketing reports. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or to establish a causal relationship to drug exposure.

  • Metabolic acidosis
  • Local infusion site reactions, including a warm sensation, erythema, phlebitis, and thrombosis at the infusion site
  • Generalized flushing, fever, and nausea

Who should not take it

Cysteine hydrochloride injection, USP is contraindicated in:

  • Patients with known hypersensitivity to one or more amino acids.
  • Patients with inborn errors of amino acid metabolism due to risk of severe metabolic or neurologic complications.
  • Patients with pulmonary edema or acidosis due to low cardiac output.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Cysteine; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/cysteine

APA 7th

sofidex. (2026, August 3). Cysteine. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/cysteine

AMA 11th

Cysteine. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/cysteine

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.